MULTITARGET DRUG DESIGN, MOLECULAR DOCKING AND PLIF STUDIES OF NOVEL TACRINE−COUMARIN HYBRIDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Fereidoonnezhad Masood; mostoufi Azar; ESKANDARI MARYAM; ZALI SAMANEH; ALIYAN FARIBA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pharmaceutical Research Year:2018 | Volume:17 | Issue:4 Page(s): 1217-1228

Download Full-Text

View:

184

Download:

149

Cites:

Information Journal Paper

Title

MULTITARGET DRUG DESIGN, MOLECULAR DOCKING AND PLIF STUDIES OF NOVEL TACRINE−COUMARIN HYBRIDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Author(s)

Keywords

MULTI-TARGET-DIRECTED LIGAND

DRUG-LIKENESS

MOLECULAR DOCKING

PLIF STUDIES

ALZHEIMER’S DISEASE

Abstract

Alzheimer’s disease (AD) as a complicated and progressive neurodegenerative disorder is the most common form of dementia and memory loss. On account of the multifactorial etiology of AD, the MULTI-TARGET-DIRECTED LIGAND (MTDL) approach is a promising method in searching new drug candidates for this disease. Here, in this paper more than 500 tacrine-coumarin hybrids have been designed and DRUG-LIKENESS, MOLECULAR DOCKING and descriptor analysis of them were performed to find out a drug candidate with less toxicity and better binding affinity than tacrine. The docking analysis was carried out using human acetylcholineesterase (1ACJ), human butyrylcholineesterase (4BDS) and b-secretase (BACE1) (1W51) enzymes using AutoDock 4.2 and Vina. The promising results were obtained on the types of interactions. Based on docking on three targets and PLIF STUDIES, the compounds that have better results were introduced as good candidates for synthesis. The validity of docking protocols was verified using a set of known active ligands and decoys on these targets.

Cites

No record.

References

No record.

Cite

APA: Copy

Fereidoonnezhad, Masood, mostoufi, Azar, ESKANDARI, MARYAM, ZALI, SAMANEH, & ALIYAN, FARIBA. (2018). MULTITARGET DRUG DESIGN, MOLECULAR DOCKING AND PLIF STUDIES OF NOVEL TACRINE?COUMARIN HYBRIDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 17(4), 1217-1228. SID. https://sid.ir/paper/288896/en

Vancouver: Copy

Fereidoonnezhad Masood, mostoufi Azar, ESKANDARI MARYAM, ZALI SAMANEH, ALIYAN FARIBA. MULTITARGET DRUG DESIGN, MOLECULAR DOCKING AND PLIF STUDIES OF NOVEL TACRINE?COUMARIN HYBRIDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2018;17(4):1217-1228. Available from: https://sid.ir/paper/288896/en

IEEE: Copy

Masood Fereidoonnezhad, Azar mostoufi, MARYAM ESKANDARI, SAMANEH ZALI, and FARIBA ALIYAN, “MULTITARGET DRUG DESIGN, MOLECULAR DOCKING AND PLIF STUDIES OF NOVEL TACRINE?COUMARIN HYBRIDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 17, no. 4, pp. 1217–1228, 2018, [Online]. Available: https://sid.ir/paper/288896/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops